Entero Therapeutics regained Nasdaq compliance by acquiring and rebranding Grid AI Corp., shifting focus to AI-driven infrastructure.

Entero Therapeutics has regained compliance with Nasdaq’s minimum stockholders’ equity requirement after acquiring Grid AI Corp., rebranding it as a wholly-owned subsidiary. The move shifts the company’s focus toward AI-driven infrastructure, including grid-edge resources, distributed energy, and cloud computing. The acquisition supports Entero’s expansion into hyperscale data center and infrastructure optimization markets, leveraging its public listing for growth. Forward-looking statements include integration and performance expectations, with risks noted.